These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26224539)

  • 1. Inhibition of differentiation and function of osteoclasts by dimethyl sulfoxide (DMSO).
    Yang C; Madhu V; Thomas C; Yang X; Du X; Dighe AS; Cui Q
    Cell Tissue Res; 2015 Dec; 362(3):577-85. PubMed ID: 26224539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
    Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
    Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation.
    Shim KS; Ma CJ; Kim DS; Ma JY
    J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
    Kim JL; Kang MK; Gong JH; Park SH; Han SY; Kang YH
    Mol Nutr Food Res; 2012 Aug; 56(8):1223-33. PubMed ID: 22700286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gingipains promote RANKL-induced osteoclastogenesis through the enhancement of integrin β3 in RAW264.7 cells.
    Mo W; Luo H; Wu J; Xu N; Zhang F; Qiu Q; Zhu W; Liang M
    J Mol Histol; 2020 Apr; 51(2):147-159. PubMed ID: 32193744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
    Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
    Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
    Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
    Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.
    Rahman MM; Bhattacharya A; Fernandes G
    J Cell Physiol; 2008 Jan; 214(1):201-9. PubMed ID: 17929247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells.
    Wu SH; Zhong ZM; Chen JT
    Int J Med Sci; 2012; 9(9):801-7. PubMed ID: 23136544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Lycii Radicis Cortex on RANKL-induced osteoclast differentiation and activation in RAW 264.7 cells.
    Kim JH; Kim EY; Lee B; Min JH; Song DU; Lim JM; Eom JW; Yeom M; Jung HS; Sohn Y
    Int J Mol Med; 2016 Mar; 37(3):649-58. PubMed ID: 26848104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways.
    Sapkota M; Li L; Choi H; Gerwick WH; Soh Y
    Eur J Pharmacol; 2015 Dec; 769():100-9. PubMed ID: 26550952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
    Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
    Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
    Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
    Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.
    Kats A; Norgård M; Wondimu Z; Koro C; Concha Quezada H; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2016 Jun; 20(6):1128-38. PubMed ID: 26987561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory cytokines in mouse placental extracts inhibit in vitro osteoclast differentiation of murine macrophages.
    Canellada A; Custidiano A; Abraham F; Rey E; Gentile T
    Placenta; 2013 Mar; 34(3):231-9. PubMed ID: 23347887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
    Chen T; Knapp AC; Wu Y; Huang J; Lynch JS; Dickson JK; Lawrence RM; Feyen JH; Agler ML
    Assay Drug Dev Technol; 2006 Aug; 4(4):387-96. PubMed ID: 16945012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell adhesion signaling regulates RANK expression in osteoclast precursors.
    Mochizuki A; Takami M; Miyamoto Y; Nakamaki T; Tomoyasu S; Kadono Y; Tanaka S; Inoue T; Kamijo R
    PLoS One; 2012; 7(11):e48795. PubMed ID: 23139818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential anti-osteoporotic activity of low-molecular weight hyaluronan by attenuation of osteoclast cell differentiation and function in vitro.
    Lee CW; Seo JY; Choi JW; Lee J; Park JW; Lee JY; Hwang KY; Park YS; Park YI
    Biochem Biophys Res Commun; 2014 Jul; 449(4):438-43. PubMed ID: 24853804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.